HCR120 — INSURANCE: Creates the PACE Task Force to prioritize access, care, and education on GLP-1 medications
Last action — Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
-
✓Introduced
-
✓In Committee
-
✓Passed House
-
✓Passed Senate
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced May 27, 2026. Enacted.
Signed by Governor Jeff Landry (Republican) on June 01, 2026.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Enacted
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 D).
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
Creates the PACE Task Force to improve access to GLP-1 medications.
This bill establishes the PACE Task Force focused on enhancing access, care, and education surrounding GLP-1 medications. The aim is to ensure better availability and understanding of these treatments.
What this means for you
- Patients: This means patients may gain better access to GLP-1 medications and improved support in understanding their use.
Summary
INSURANCE: Creates the PACE Task Force to prioritize access, care, and education on GLP-1 medications
Bill Text
We don't have the full text on file for this bill yet.
Read HCR120 on the official Louisiana source →Action History
-
Read by title. Lies over under the rules.
-
Read by title, rules suspended, passed to 3rd reading.
-
Scheduled for floor debate on 05/31/2026.
-
Rules suspended, called out of its regular order.
-
Read by title, roll called on final consideration, yeas 81, nays 11. The resolution was adopted and ordered to the Senate.
-
Received in the Senate; read by title. Rules suspended. Read second time by title and concurred in by a vote of 33 yeas and 0 nays. Ordered returned to the House.
-
Received from the Senate without amendments.
-
Enrolled and signed by the Speaker of the House.
-
Signed by the President of the Senate.
-
Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
Sponsors
- Rodney Lyons · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 146 not signed on
Sponsors (1)
- Rodney Lyons Democrat
Co-sponsors (0)
None.
Not signed on (146)
146 members have not signed on to this bill.
Show all 146 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HCR120 do?
- INSURANCE: Creates the PACE Task Force to prioritize access, care, and education on GLP-1 medications
- Who sponsors HCR120?
- HCR120 is sponsored by Rodney Lyons (Democrat).
- What is the current status of HCR120?
- This bill has been enacted into law. Introduced May 27, 2026. Enacted.
- Where can I track HCR120?
- Track HCR120 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HCR120
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HCR120
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →